ArticleRSC advances2025
Facile calixarene-based sensor array strategy for quality evaluation of Yinxing Mihuan oral solution.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prospects and challenges of traditional Chinese medicine supramolecular nano-drug delivery systems in the treatment of cerebral ischemia.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To facilitate efficient and rapid quality evaluation of traditional Chinese medicine (TCM) preparations, we introduced an innovative macrocycle-based fluorescence sensing strategy. Herein, an array of calixarene-based sensors was designed to assess the batch-to-batch consistency and precise feeding of raw materials of Yinxing Mihuan oral solution (YMOS), which is used to treat cardiovascular and cerebrovascular diseases in the clinic, highlighting the feasibility of the established supramolecular fluorescence sensing method. Using indicator displacement assay (IDA), the molecular recognition between calixarenes and the tested compounds from YMOS was converted into multi-fluorescence signals by extruding the indicators from their respective hosts, whose mechanisms were unveiled by theoretical calculations. By employing the constructed three-element sensor array, a standard fluorescent fingerprint was displayed by "spider-web" mode to evaluate the quality consistency of the YMOS samples. Moreover, the optimized QAC5A·EY reporter pair was successfully applied to guarantee precise feeding of raw materials during the manufacturing process of YMOS. The calixarene-based sensor array method offers a comprehensive evaluation for YMOS in a facile and high-throughput style, conducive to improving quality evaluation of TCM.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.